Back to Trades
Other4
ROCKET PHARMACEUTICALS, INC.
RCKT
Total Value
$45.3M
Company Information
- Company Name
- ROCKET PHARMACEUTICALS, INC.
- Ticker Symbol
- RCKT
- CIK
- 0001281895
Insider Information
- Role
- Insider
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Sep 23, 2025
- Transaction Date
- Sep 19, 2025
- Accession Number
- 0001231919-25-000232
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Common Stock | 1,000,000 | $40.03 | Exercise | $40.0M |
| Sep 19, 2025 | Common Stock | 1,000,000 | $3.10 | Other | $3.1M |
| Sep 19, 2025 | Common Stock | 41,000 | $19.09 | Exercise | $782.8K |
| Sep 19, 2025 | Common Stock | 41,000 | $3.10 | Other | $127.3K |
| Sep 19, 2025 | Common Stock | 59,000 | $17.81 | Exercise | $1.1M |
| Sep 19, 2025 | Common Stock | 59,000 | $3.10 | Other | $183.2K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 19, 2025 | Derivative | 1 | $40.03 | Exercise | $40 |
| Sep 19, 2025 | Derivative | 1 | $19.09 | Exercise | $19 |
| Sep 19, 2025 | Derivative | 1 | $17.81 | Exercise | $18 |
Footnotes
- (F1)On September 19, 2025, the equity swap entered into by RTW Innovation Master Fund, Ltd. previously reported on the Forms 4 filed by the Reporting Persons on May 13, 2021 and April 5, 2023, expired and settled in accordance with its terms. After the transaction reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.
- (F2)This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.
- (F3)On September 19, 2025, the equity swap entered into by RTW Innovation Master Fund, Ltd previously reported on the Form 4 filed by the Reporting Persons on December 22, 2022 expired and settled in accordance with its terms. After the transaction reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.
- (F4)On September 19, 2025, the equity swap entered into by RTW Innovation Master Fund, Ltd previously reported on the Form 4 filed by the Reporting Persons on December 23, 2022 expired and settled in accordance with its terms. After the transaction reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.
- (F5)Represents restricted stock units ("RSUs") held by Dr. Wong that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.